These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 19959508

  • 21. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 22. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
    Idée JM, Port M, Dencausse A, Lancelot E, Corot C.
    Radiol Clin North Am; 2009 Sep; 47(5):855-69, vii. PubMed ID: 19744600
    [Abstract] [Full Text] [Related]

  • 23. Nephrogenic systemic fibrosis: clinical spectrum of disease.
    Mayr M, Burkhalter F, Bongartz G.
    J Magn Reson Imaging; 2009 Dec; 30(6):1289-97. PubMed ID: 19937929
    [Abstract] [Full Text] [Related]

  • 24. Update on nephrogenic systemic fibrosis.
    Thomsen HS, Marckmann P, Logager VB.
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
    [Abstract] [Full Text] [Related]

  • 25. Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
    Lemy AA, del Marmol V, Kolivras A, High WA, Matos C, Laporte M, Nortier JL.
    J Am Acad Dermatol; 2010 Sep; 63(3):389-99. PubMed ID: 20619488
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K, Maeda T, Watanabe S, Ueno Y, Sugimura K.
    Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
    [Abstract] [Full Text] [Related]

  • 28. Current status of nephrogenic systemic fibrosis.
    Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H.
    Clin Radiol; 2014 Jul; 69(7):661-8. PubMed ID: 24582176
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Gadolinium and nephrogenic systemic fibrosis: have we overreacted?
    Penfield JG, Reilly RF.
    Semin Dial; 2011 Jul; 24(5):480-6. PubMed ID: 21913988
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital.
    Zou Z, Ma L, Li H.
    J Magn Reson Imaging; 2009 Dec; 30(6):1309-12. PubMed ID: 19937931
    [Abstract] [Full Text] [Related]

  • 33. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
    Wilford C, Fine JD, Boyd AS, Sanyal S, Abraham JL, Kantrow SM.
    Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
    [Abstract] [Full Text] [Related]

  • 34. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
    Heinz-Peer G, Neruda A, Watschinger B, Vychytil A, Geusau A, Haumer M, Weber M.
    Eur J Radiol; 2010 Oct; 76(1):129-34. PubMed ID: 19619969
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.